Odyssey Health, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $1.0M
- Price
- $0.01
- % Change (Daily % change from the live per-ticker quote feed.)
- +2.04%
- Volume
- 494.0K
About
Odyssey Health, Inc. operates as a medical enterprise, primarily focused on the innovation and development of diverse healthcare products. Its current portfolio encompasses CardioMap, an advanced device for cardiac monitoring and screening, alongside the "Save A Life" line of devices engineered for choking emergencies. Additionally, the company is advancing neurosteroid drug compounds, PRV-001 and PRV-002, intended for the treatment of concussive injuries and various rare brain disorders. The organization, established in 2014 and headquartered in Las Vegas, Nevada, was previously known as Odyssey Group International, Inc.
Quick stats
Shares outstanding101.0M
Computed float178.9M
Float / shares177.1%
Cash runway (months)-0.7
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001626644
AI Summary
AI-generated1/3
standardbullishpartnership
Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth
Odyssey Health secured exclusive global marketing and distribution rights for BreastCheck™, a non-invasive at-home screening device for breast abnormalities.
The device is registered with the FDA and authorities in the EU and UK, targeting a global market estimated at approximately $26 billion with results available in roughly 15 minutes.
Management expects commercial sales to begin in the second half of the year, marking a strategic shift toward recurring revenue.